BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1810490)

  • 1. [The reaction of the mast cell population to the intratracheal administration of heparin and fucoidan].
    Rumiantseva AG; Kotel'nikov VM; Rozkin MIa; Efimov VS
    Biull Eksp Biol Med; 1991 Nov; 112(11):507-9. PubMed ID: 1810490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of intratracheal administration of heparin on the status of the mast cell population in the rat].
    Orlova AG; Chernova OV; Rozkin MIa; Efimov VS
    Farmakol Toksikol; 1989; 52(3):55-9. PubMed ID: 2792355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR123781A, a synthetic heparin mimetic.
    Herbert JM; Hérault JP; Bernat A; Savi P; Schaeffer P; Driguez PA; Duchaussoy P; Petitou M
    Thromb Haemost; 2001 May; 85(5):852-60. PubMed ID: 11372679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the quaternary ammonium salts of the monodisperse oligomers of conidine on a mast cell population].
    Efimov VS; Poberiĭ IA; Chernova OV; Pereverzev AI
    Farmakol Toksikol; 1984; 47(6):50-3. PubMed ID: 6519256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic and anticoagulant activities of a low molecular weight fucoidan by the subcutaneous route.
    Millet J; Jouault SC; Mauray S; Theveniaux J; Sternberg C; Boisson Vidal C; Fischer AM
    Thromb Haemost; 1999 Mar; 81(3):391-5. PubMed ID: 10102467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The incorporation of 35S-heparin into mast cells in the rat and its release into the circulatory bed].
    Umarova BA; Shapiro FB; Khlgatian SV; Strukova SM
    Biull Eksp Biol Med; 1989 Dec; 108(12):648-51. PubMed ID: 2634431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The behavior of unfractionated and low-molecular heparin in the body of the rat].
    Khlgatian SV; Umarova BA; Sahpiro FB; Strukova SM
    Dokl Akad Nauk SSSR; 1990; 313(2):509-11. PubMed ID: 1963137
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamics of the anticoagulant activity (APTT) of an algal polysaccharide.
    Cattaneo F; Trento F; Pescador R; Porta R; Ferro L
    Thromb Res; 2002 Mar; 105(5):455-7. PubMed ID: 12062548
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of trophoblast-specific beta 1-glycoprotein on the ratio of cellular forms in a mast cell population].
    Sidorov NM; Krivonosov SK; Golovistikov IN; Mironov AA; Pogorelova TIu
    Ontogenez; 1988; 19(2):213-7. PubMed ID: 3260366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seasonal changes in the cytochemical properties of the peritoneal mast cells in rats].
    Gordon DS; Bochkarev VA; Stepanova GN
    Arkh Anat Gistol Embriol; 1991; 101(9-10):81-4. PubMed ID: 1845521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of long-term hypocoagulability in rats after intratracheal administration of unfractionated heparin.
    Efimov VS; Rumyantseva AG; Golovlyova OA; Rozkin MYa
    Thromb Res; 1993 Feb; 69(3):307-13. PubMed ID: 7682732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of immunomodulators that stimulate macrophagal functional activity on the morphofunctional characteristics of mast cells].
    Bochkarev VA; Kupriianov VS
    Tsitologiia; 1994; 36(9-10):960-5. PubMed ID: 7701624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The dynamics of the body distribution of heparin and its antagonist, the quaternary ammonium salt of conidine oligomer-25, when administered via the lungs].
    Rumiantsev AG; Golovleva OA; Rozkin MIa; Kazarian VA; Efimov VS
    Farmakol Toksikol; 1991; 54(1):49-51. PubMed ID: 1860499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
    Atkins FM; Metcalfe DD
    J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell secretion. Rapid sealing of exocytotic cavities demonstrated by cytofluorometry.
    Berlin G; Enerbäck L
    Int Arch Allergy Appl Immunol; 1984; 73(3):256-62. PubMed ID: 6199311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous absorption of heparin: a critical review of experimental results].
    Sznitowska M; Janicki S
    Pol Merkur Lekarski; 2000 Jan; 7(43):58-63. PubMed ID: 10765658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells.
    Feyerabend TB; Li JP; Lindahl U; Rodewald HR
    Nat Chem Biol; 2006 Apr; 2(4):195-6. PubMed ID: 16532012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The reaction of mast cells to the administration of solutions of NaCl, heparin and histamine].
    Vorob'eva NF; Vinogradov VV
    Arkh Patol; 1967; 29(8):57-61. PubMed ID: 5602142
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphometric analysis of a mast cell population].
    Linder DP; Poberiĭ IA; Rozkin MIa; Efimov VS
    Arkh Patol; 1980; 42(6):60-4. PubMed ID: 6998431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.